Terms: = Bone cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Treatment
207 results:
1. Favorable impact of PD1/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validation.
Gassner T; Chittilappilly C; Pirich T; Neuditschko B; Hackner K; Lind J; Aksoy O; Graichen U; Klee S; Herzog F; Wiesner C; Errhalt P; Pecherstorfer M; Podar K; Vallet S
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38702145
[TBL] [Abstract] [Full Text] [Related]
2. An IL-1β-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma.
de Jong MME; Fokkema C; Papazian N; Czeti Á; Appelman MK; Vermeulen M; van Heusden T; Hoogenboezem RM; van Beek G; Tahri S; Sanders MA; van de Woestijne PC; Gay F; Moreau P; Büttner-Herold M; Bruns H; van Duin M; Broijl A; Sonneveld P; Cupedo T
Nat Immunol; 2024 May; 25(5):820-833. PubMed ID: 38600356
[TBL] [Abstract] [Full Text] [Related]
3. Screening for Synergistic Reagents With Pazopanib Against Osteosarcoma Using a Compound Library.
Yada Y; Asanuma K; Kakimto T; Okuno K; Okamoto T; Iino T; Nakamura T; Sudo A
Anticancer Res; 2024 Mar; 44(3):1071-1078. PubMed ID: 38423639
[TBL] [Abstract] [Full Text] [Related]
4. Corticosteroids impair epithelial regeneration in immune-mediated intestinal damage.
Arnhold V; Chang WY; Jansen SA; Thangavelu G; Calafiore M; Vinci P; Fu YY; Ito T; Takashima S; Egorova A; Kuttiyara J; Perlstein A; van Hoesel M; Liu C; Blazar BR; Lindemans CA; Hanash AM
J Clin Invest; 2024 Feb; 134(7):. PubMed ID: 38349762
[TBL] [Abstract] [Full Text] [Related]
5. Activation of HDAC8 Can Suppress the Proliferation of Osteosarcoma Cells via
Wang L; Bai X; Zhang X; Wang X; Chen S; Wu S; Lin L
Ann Clin Lab Sci; 2023 Nov; 53(6):920-930. PubMed ID: 38182151
[TBL] [Abstract] [Full Text] [Related]
6. Morin inhibits osteosarcoma migration and invasion by suppressing urokinase plasminogen activator through a signal transducer and an activator of transcription 3.
Yang JS; Chou CH; Hsieh YH; Lu PW; Lin YC; Yang SF; Lu KH
Environ Toxicol; 2024 Apr; 39(4):2024-2031. PubMed ID: 38093596
[TBL] [Abstract] [Full Text] [Related]
7. The highs and lows of cyclic thrombocytopenia.
Zhang H; Villar-Prados A; Bussel JB; Zehnder JL
Br J Haematol; 2024 Jan; 204(1):56-67. PubMed ID: 38083878
[TBL] [Abstract] [Full Text] [Related]
8. Bazedoxifene Suppresses the Growth of Osteosarcoma Cells by Inhibiting IL-6 and IL-11/GP130 Signaling Pathway.
Wu X; Cao Y; Xiao H; Feng J; Lin J
J Pediatr Hematol Oncol; 2024 Jan; 46(1):8-14. PubMed ID: 37962127
[TBL] [Abstract] [Full Text] [Related]
9. Eicosapentaenoic acid enhances the sensitivity of osteosarcoma to cisplatin by inducing ferroptosis through the DNA-PKcs/AKT/NRF2 pathway and reducing PD-L1 expression to attenuate immune evasion.
Zhang Y; Shen G; Meng T; Lv Z; Li X; Li J; Li K
Int Immunopharmacol; 2023 Dec; 125(Pt B):111181. PubMed ID: 37951196
[TBL] [Abstract] [Full Text] [Related]
10. JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study.
Fischer M; Olbrich P; Hadjadj J; Aumann V; Bakhtiar S; Barlogis V; von Bismarck P; Bloomfield M; Booth C; Buddingh EP; Cagdas D; Castelle M; Chan AY; Chandrakasan S; Chetty K; Cougoul P; Crickx E; Dara J; Deyà-Martínez A; Farmand S; Formankova R; Gennery AR; Gonzalez-Granado LI; Hagin D; Hanitsch LG; Hanzlikovà J; Hauck F; Ivorra-Cortés J; Kisand K; Kiykim A; Körholz J; Leahy TR; van Montfrans J; Nademi Z; Nelken B; Parikh S; Plado S; Ramakers J; Redlich A; Rieux-Laucat F; Rivière JG; Rodina Y; Júnior PR; Salou S; Schuetz C; Shcherbina A; Slatter MA; Touzot F; Unal E; Lankester AC; Burns S; Seppänen MRJ; Neth O; Albert MH; Ehl S; Neven B; Speckmann C
J Allergy Clin Immunol; 2024 Jan; 153(1):275-286.e18. PubMed ID: 37935260
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
12. SIRP-alpha-IL-6 axis induces immunosuppressive macrophages in non-small-cell lung cancer.
Wang B; Pan L; Chen M; Ma Y; Gao J; Tang D; Jiang Z
Biochem Biophys Res Commun; 2023 Nov; 682():386-396. PubMed ID: 37844448
[TBL] [Abstract] [Full Text] [Related]
13. Possible Role of IL-6R/stat3/MiRNA-34a Feedback Loop in Osteosarcoma.
Amer MF; Mohamed A; Ismail A; Bayoumi LA; Shibel PEE; Elnaggar GN
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3269-3274. PubMed ID: 37774081
[TBL] [Abstract] [Full Text] [Related]
14. Chronic inflammation promotes cancer progression as a second hit.
Burocziova M; Grusanovic S; Vanickova K; Kosanovic S; Alberich-Jorda M
Exp Hematol; 2023 Dec; 128():30-37. PubMed ID: 37709251
[TBL] [Abstract] [Full Text] [Related]
15. Circular RNAs in osteosarcoma: An update of recent studies (Review).
Zeng L; Liu L; Ni WJ; Xie F; Leng XM
Int J Oncol; 2023 Nov; 63(5):. PubMed ID: 37681483
[TBL] [Abstract] [Full Text] [Related]
16. Highly proliferative and hypodifferentiated CAR-T cells targeting B7-H3 enhance antitumor activity against ovarian and triple-negative breast cancers.
Zhang X; Guo H; Chen J; Xu C; Wang L; Ke Y; Gao Y; Zhang B; Zhu J
Cancer Lett; 2023 Sep; 572():216355. PubMed ID: 37597651
[TBL] [Abstract] [Full Text] [Related]
17. Comparing the value of mono- vs coculture for high-throughput compound screening in hematological malignancies.
Herbst SA; Kim V; Roider T; Schitter EC; Bruch PM; Liebers N; Kolb C; Knoll M; Lu J; Dreger P; Müller-Tidow C; Zenz T; Huber W; Dietrich S
Blood Adv; 2023 Oct; 7(19):5925-5936. PubMed ID: 37352275
[TBL] [Abstract] [Full Text] [Related]
18. Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6/JAK2/stat3 signaling.
Lu J; Dong Q; Zhang S; Feng Y; Yang J; Zhao L
Cancer Sci; 2023 Aug; 114(8):3287-3300. PubMed ID: 37272257
[TBL] [Abstract] [Full Text] [Related]
19. Resveratrol Loaded by Folate-Modified Liposomes Inhibits Osteosarcoma Growth and Lung Metastasis via Regulating JAK2/stat3 Pathway.
Zhu WT; Zeng XF; Yang H; Jia ML; Zhang W; Liu W; Liu SY
Int J Nanomedicine; 2023; 18():2677-2691. PubMed ID: 37228445
[TBL] [Abstract] [Full Text] [Related]
20. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
[TBL] [Abstract] [Full Text] [Related]
[Next]
